We’re very pleased to announce the winners for the 2017 Buzz of BIO contest of the BIO International Convention.
Remember, you can still apply to present at the BIO International Convention. Company presenters tend to receive double the number of requests than non-presenters, and schedule twice as many meetings than non-presenting companies. Learn more and apply here.
We’re pleased to introduce you to our winners:
Technologies of Tomorrow
Nanopareil, LLC produces ultra-high capacity single-use nanofiber membranes and 3D nanofiber scaffolds for the biopharmaceutical and biomedical industries. The company’s patented nanotechnology and specialty treatments provide outstanding purification capabilities and transformative 3D tissue engineering scaffolds. Nanopareil’s ultra-high capacity, high flow membranes are changing bioseparations, enabling single-use processing, which reduces the risk of contamination, decreasing GMP deviations and significantly lowering the cost of purification of vaccines and biopharmaceuticals. Nanopareil’s 3D scaffolds with interconnected and hierarchy structured pore morphology, uniquely replicate the extracellular matrix of many tissues.
Pipelines of Promise
PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it has filed a provisional patent application with the United States Patent and Trademark Office (USPTO) to protect its therapy to treat cancerous tumors, including the therapy that will be used in its upcoming clinical trial in locally advanced pancreas cancer (LAPC).
You’ll definitely want to see these companies present at the BIO International Convention in San Diego this June.
Thanks to everyone who participated!